Skip to content

INVA

Innoviva, Inc.

NASDAQ · Healthcare · Biotechnology · US

$21.19
−0.76%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-5.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 24, 2026Basso Stephen · officer: Chief Financial OfficerF-InKind558$21
Aug 24, 2026Raifeld Pavel · director, officer: Chief Executive OfficerF-InKind1,130$21
Aug 24, 2026Zhen Marianne · officer: Chief Accounting OfficerF-InKind1,127$21
May 22, 2026Basso Stephen · officer: Chief Financial OfficerA-Award1,123$0.00
May 22, 2026Basso Stephen · officer: Chief Financial OfficerF-InKind559$22
May 22, 2026Raifeld Pavel · director, officer: Chief Executive OfficerA-Award1,123$0.00
May 22, 2026Zhen Marianne · officer: Chief Accounting OfficerF-InKind1,127$22
May 22, 2026Raifeld Pavel · director, officer: Chief Executive OfficerF-InKind1,130$22
May 20, 2026Linden Josephine · directorA-Award9,461$0.00
May 20, 2026Linden Josephine · directorA-Award9,166$22
May 20, 2026Linden Josephine · directorA-Award5,733$0.00
May 6, 2026Basso Stephen · officer: Chief Financial OfficerA-Award93,750$23
May 6, 2026Schlesinger Sarah J. · directorA-Award9,786$0.00
May 6, 2026Small Derek A · directorA-Award9,786$0.00
May 6, 2026DiPaolo Mark · directorA-Award9,786$0.00
May 6, 2026Haimovitz Jules · directorA-Award9,786$0.00
May 6, 2026Raifeld Pavel · director, officer: Chief Executive OfficerA-Award126,646$0.00
May 6, 2026Haimovitz Jules · directorA-Award10,000$23
May 6, 2026Small Derek A · directorA-Award10,000$23
May 6, 2026Zhen Marianne · officer: Chief Accounting OfficerA-Award31,500$23
May 6, 2026DiPaolo Mark · directorA-Award10,000$23
May 6, 2026Raifeld Pavel · director, officer: Chief Executive OfficerA-Award312,500$23
May 6, 2026Zhen Marianne · officer: Chief Accounting OfficerA-Award12,766$0.00
May 6, 2026Basso Stephen · officer: Chief Financial OfficerA-Award37,994$0.00
May 6, 2026Schlesinger Sarah J. · directorA-Award10,000$23
Feb 24, 2026Zhen Marianne · officer: Chief Accounting OfficerF-InKind2,460$23
Feb 24, 2026Raifeld Pavel · director, officer: Chief Executive OfficerF-InKind2,986$23
Feb 24, 2026Basso Stephen · officer: Chief Financial OfficerF-InKind1,244$23
Nov 24, 2025Basso Stephen · officer: Chief Financial OfficerA-Award604$0.00
Nov 24, 2025Zhen Marianne · officer: Chief Accounting OfficerF-InKind992$21
Institutional positioning

13F filings over the trailing two quarters

New 96Increased 245Reduced 177Sold out 24
FilerActionSharesFiled
BlackRock, Inc.Increased11,555,209Aug 7, 2026
BLACKROCK, INC.Increased11,307,845May 13, 2026
DIMENSIONAL FUND ADVISORS LPIncreased4,494,053Aug 11, 2026
DIMENSIONAL FUND ADVISORS LPIncreased4,436,427May 7, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position4,224,951May 8, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCReduced4,220,273Aug 13, 2026
RENAISSANCE TECHNOLOGIES LLCReduced4,055,632May 14, 2026
RENAISSANCE TECHNOLOGIES LLCReduced4,036,532Aug 13, 2026
STATE STREET CORPIncreased3,268,004Aug 7, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased3,158,053Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position3,141,581May 15, 2026
STATE STREET CORPIncreased3,060,377May 15, 2026
MILLENNIUM MANAGEMENT LLCIncreased2,541,109Aug 14, 2026
MILLENNIUM MANAGEMENT LLCIncreased2,279,451May 15, 2026
SARISSA CAPITAL MANAGEMENT LPReduced2,130,950May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 24, 2026